Home›Stock Screener›Global Health

Global Health Share Price Today | Stock Price & Global Health Share Screener

MEDANTA Healthcare Services
Live Share Price NSE
₹1436.60
▼ -7.60 (-0.53%)
2026-11-18 00:00:00
Live Share Price BSE
₹1434.80
▼ -7.90 (-0.55%)
2026-11-18 00:00:00

As of November 18, 2026, the live Global Health share price (NSE: MEDANTA) is ₹1,436.60 on NSE and ₹1,434.80 on BSE, down 0.53% from the previous close, with shares trading between ₹1,424.00 and ₹1,467.90 in today's trading session, and a 52-week range of ₹961.10–₹1,508.90. Track MEDANTA market value to gauge the company's total market size. Use the Global Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Global Health opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,196 and net income of ₹142, with EBITDA of ₹281, an operating margin of 21.0% and a profit margin of 11.9%.

Global Health Market Cap ₹38,830.46 Cr.
MEDANTA P/E Ratio (TTM) 62.80
Global Health P/B Ratio 8.91
EPS (TTM) ₹20.71
Dividend Yield 0.03%
Debt to Equity 0.26
MEDANTA 52 Week High ₹1508.90
Global Health 52 Week Low ₹961.10
Operating Margin 21.00%
Profit Margin 11.87%
MEDANTA Revenue (TTM) ₹1,196.00
EBITDA ₹281.00
Net Income ₹142.00
Total Assets ₹5,905.00
Total Equity ₹3,984.00

Global Health Share Price Chart

Track the current stock price of Global Health with an interactive chart. Analyse MEDANTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Global Health stock quote in one place.

The quote of ₹1,436.60 sits between the 52-week low of ₹961.10 and the 52-week high of ₹1,508.90, and the latest session moved -0.53% from the previous close.

Global Health Company Profile - Fundamental Screener

Screen Global Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDANTA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, with Naresh Kumar Trehan listed as chairperson or CEO, and it trades under ISIN INE474Q01031.

Business Overview

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over...more

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

Chairperson/CEO Naresh Kumar Trehan
ISIN INE474Q01031

Global Health Balance Sheet Screener

Screen MEDANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹5,905, up from ₹4,766 in 2025.

Latest statistics put total assets at ₹5,905 and shareholder funds at ₹3,984, with a leverage ratio of 0.26.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018

Assets

Total Assets 5,905 4,766 4,304 4,116 3,146 2,694 0 2,430 1,984
Current Assets 0 0 0 0 0 0 0 0 0
Fixed Assets 3,795 2,514 2,236 2,050 1,776 1,616 0 1,194 1,094

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0
Current Liabilities 1,294 760 781 1,115 1,110 907 0 839 432
Non-Current Liabilities 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 3,984 3,388 2,906 2,428 1,616 1,382 0 1,296 1,217
Share Capital 54 54 54 54 51 50 0 49 81
Reserves & Surplus 3,908 3,333 2,852 2,375 1,565 1,300 0 1,214 1,136

Global Health Income Statement Screener - Profit & Revenue Analysis

Screen Global Health income statement and profit fundamentals. Analyze MEDANTA quarterly results. Global Health reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹1,196 and net profit was ₹142, equal to earnings per unit of ₹5.36, at an operating margin of 21%.

In that period expenses were ₹915, interest cost ₹27 and tax ₹46. The next period listed, 2026-Jun, shows revenue of ₹1,326 and net profit of ₹157.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 1,196 1,326 1,493 954 1,051 1,135 1,143 836 883 975 960 732 795 865 855
Expenses 915 1,017 1,099 757 784 868 940 629 675 728 706 540 595 631 621

Operating Costs and Margins

EBITDA 281 309 394 198 267 267 203 207 208 247 254 192 199 234 234
Operating Profit % 21.00% 22.00% 25.00% 19.00% 24.00% 21.00% 16.00% 22.00% 22.00% 24.00% 25.00% 24.00% 24.00% 25.00% 26.00%
Depreciation 67 69 71 49 45 50 61 46 47 49 49 38 40 43 44
Interest 27 27 28 15 14 17 22 18 18 16 16 21 18 20 18

Profit and Earnings

Profit Before Tax 187 213 295 133 208 200 120 143 144 181 189 133 141 171 172
Tax 46 56 76 32 49 41 25 16 37 50 46 32 39 45 49
Net Profit 142 157 219 101 159 158 95 127 106 131 143 101 102 125 124
EPS 5.36 5.91 8.21 3.77 5.92 5.89 3.54 4.74 3.96 4.87 5.32 3.77 3.80 4.66 4.61

Global Health Cash Flow Screener - Liquidity Fundamentals

Screen MEDANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹714, and net cash flow was an outflow of ₹103.

Over the same period, investing activities used ₹1,089 and financing activities provided ₹272.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2016-March

Cash from Operations and Investing

Operating Activities 714 624 612 645 311 242 175 166 63 228
Investing Activities -1,089 -721 -441 -342 -421 -239 -87 -249 -69 -241

Financing and Net Cash

Financing Activities 272 -97 -514 346 160 -81 -1 97 9 -7
Net Cash Flow -103 -194 -343 648 50 -78 87 14 3 -20

Global Health Shareholding Pattern Screener

See Global Health shareholding pattern with promoter, FII, and DII holdings. Check Global Health promoter holding and ownership changes for MEDANTA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 33.01%, foreign institutions 10.15%, domestic institutions 14.77% and the public 5.88%, spread across 147,390 shareholders.

The shareholder count was 147,390 in 2026-Mar, compared with 140,531 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 33.01% 33.00% 33.00% 33.03% 33.01% 33.01% 33.01% 33.04%

Institutional Investors

FII Holding 10.15% 9.46% 9.91% 11.76% 11.54% 11.40% 10.53% 12.09%
DII Holding 14.77% 16.89% 17.01% 11.93% 12.20% 12.98% 14.00% 10.25%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 5.88% 5.60% 5.40% 6.53% 6.48% 6.03% 5.95% 7.14%
Other Holding 36.20% 35.05% 34.68% 36.75% 36.77% 36.58% 36.51% 37.47%
Shareholder Count 147,390 140,531 135,371 154,688 156,372 155,806 151,241 166,253

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Global Health. Global Health dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.03%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.50 0.03%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Global Health Stock Index Membership - Nifty & Sensex

See which indices include Global Health stock. Check MEDANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 19 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX BSEIPO.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX BSEIPO
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MSL400
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY LARGEMID250
NIFTY MIDCAP 150
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

Global Health Market Events Screener - Corporate Actions

Get Global Health corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Global Health stock events that may affect MEDANTA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Annual General Meeting dated September 16, 2026 and Dividend dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-03 2026-11-03 Quarterly Result Announcement NA 5.36%
2026-09-16 2026-09-16 Annual General Meeting NA -1.01%
2026-08-14 2026-08-14 Dividend ₹ 0.50 /share 17.93%
2026-07-30 2026-07-30 Quarterly Result Announcement NA 8.78%
2026-05-14 2026-05-14 Quarterly Result Announcement NA 2.20%
2026-02-04 2026-02-04 Quarterly Result Announcement NA 8.16%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -5.04%
2025-09-19 2025-09-19 Annual General Meeting NA 2.14%
2025-08-22 2025-08-22 Dividend ₹ 0.50 /share 11.88%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -1.20%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 3.17%
2025-02-04 2025-02-04 Quarterly Result Announcement NA 4.13%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -3.80%
2024-09-19 2024-09-19 Annual General Meeting NA -6.51%
2024-08-03 2024-08-03 Extraordinary General Meeting NA -7.46%

Global Health Competitors Screener - Peer Stocks Comparison

Screen MEDANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 125,272 53.90 25,420 15.58% 2,003 61.89
Max Healthcare Institute 100,339 71.20 8,536 18.82% 1,442 76.17
Manipal Health Enterprises 92,333 104.20 10,521 25.80% 917 60.80
Aster DM Quality Care 64,325 116.10 4,769 11.25% 427 57.55
Fortis Healthcare 60,910 57.00 9,179 16.93% 1,064 57.30
Global Health 38,830 62.80 4,509 19.56% 554 64.64
Narayana Hrudayalaya 38,984 45.00 7,996 43.43% 811 61.49
Dr. Lal Path Labs 33,237 57.20 2,864 12.11% 510 54.28
Krishna Institute of Medical Sciences 32,269 163.00 3,931 28.16% 242 66.73
Syngene International 17,533 95.70 3,809 2.56% 317 61.78

Global Health Company Announcements - News & Reports Screener

Screen MEDANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 18, 2026.

The next most recent announcements are dated November 16, 2026 and November 12, 2026.

Date Update Actions
2026-11-18 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-16 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-12 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-03 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-03 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-03 Announcement Under Regulation 30 Of Listing Regulations. -
2026-11-03 Results For The Quarter & Half Year Ended September 30 2026 -
2026-11-03 Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations 2015 -
2026-11-02 Announcement under Regulation 30 (LODR)-Change in Management -
2026-11-02 Announcement under Regulation 30 (LODR)-Meeting Updates -
2026-10-31 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-27 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-23 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-22 Board Meeting Intimation for Board Meeting Intimation For Schedule Of Board Meeting For The Second Quarter & Half Year Ended September 30 2026 Under Regulation 29 Of SEBI (LODR) 2015. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,436.60, within a 52-week range of ₹961.10 to ₹1,508.90. The P/E ratio is 62.80 and the P/B ratio is 8.91, with earnings per unit of ₹20.71. Market capitalisation stands at ₹38,830.46 Cr and the dividend yield is 0.03%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.